Patritumab Deruxtecan Biosimilar - Research Grade
Product Sizes
1mg
ICH5206D-1MG
5mg
ICH5206D-5MG
About this Product
- SKU:
- ICH5206D
- Additional Names:
- Dxd
- Application:
- Cell-based/Functional Assay
- CE/IVD:
- RUO
- Clonality:
- Recombinant Monoclonal
- Concentration:
- 1mg/ml
- Extra Details:
- Anti-ERBB3/ HER3 Reference Antibody (Patritumab deruxtecan) is a novel ADC composed of an anti-HER3 antibody (Patritumab) and a novel potent topoisomerase I inhibitor DX-8951,conjugated, on an average of 8 cysteinyl, to deruxtecan, comprising a linker and a camptothecin derivative.
- Formulation:
- 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
- Immunogen:
- ERBB3 / HER3
- Isotype:
- IgG1
- Purity:
- >90% by SDS-PAGE
- Reactivities:
- Human
- Shipping Conditions:
- Ambient
- Storage Conditions:
- This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
- Supplier:
- ichorbio
- Type:
- Antibodies:Monoclonal Antibody
- Manufacturer's Data Sheet:patritumab-deruxtecan-biosimilar-research-grade-ich5206d
